Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Filings indexed 613 across all filing types
Latest filing 2023-12-04 Major Shareholding Noti…
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings
Major Shareholding Notification Classification · 99% confidence The document is titled 'Optomed Oyj - Major shareholder announcements' and explicitly mentions 'Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings'. It details a change in the percentage of shares and voting rights held by a specific entity ('Cenova Capital'), crossing a threshold. This type of filing, reporting changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). The document length is relatively short (4734 chars) and contains specific regulatory disclosure details rather than a full financial report.
2023-12-04 English
Arvopaperimarkkinalain 9 luvun 10 §:ssä tarkoitettu ilmoitus omistusosuuden muutoksesta
Major Shareholding Notification Classification · 99% confidence The document is a 'Pörssitiedote' (Stock Exchange Release) from Optomed Oyj, dated 4.12.2023. The title explicitly mentions 'Arvopaperimarkkinalain 9 luvun 10 §:ssä tarkoitettu ilmoitus omistusosuuden muutoksesta' (Notification pursuant to Chapter 9, Section 10 of the Securities Markets Act regarding a change in holding). This type of filing reports changes in significant shareholdings or voting rights, which directly corresponds to the definition of Major Shareholding Notification (MRQ). The content details the new percentage holding (3.81%) and the previous holding (9.96%) of Cenova Capital in Optomed.
2023-12-04 Finnish
11037825.pdf
Interim / Quarterly Report Classification · 100% confidence The document is an 'Osavuosikatsaus' (Interim Report) for Optomed Oyj covering the period of January to September 2023. It contains detailed financial statements, segment analysis (Devices and Software), key performance indicators, and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2023
2023-11-03 Finnish
Optomed Oyj:n osavuosikatsaus, tammi-syyskuu 2023
Interim / Quarterly Report Classification · 100% confidence The document is an 'osavuosikatsaus' (interim report) for Optomed Oyj covering the period of January to September 2023. It contains detailed financial statements, segment analysis (Laitteet and Ohjelmistot), key performance indicators (Avainluvut), and management commentary. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2023
2023-11-03 Finnish
11037826.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report, January – September 2023' and contains comprehensive financial statements, segment performance analysis, key figures, and management commentary for the specified period. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-03 English
Optomed Plc: Interim report, January - September 2023
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report titled 'Interim report, January - September 2023' for Optomed Plc. It contains detailed financial statements, segment performance analysis (Devices and Software), key figures, and management commentary. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.